Speaker Profile
M.D., Ph.D., President, Research and Development, Kyverna Tx
Biography
Dominic Borie is an accomplished immunologist and transplant surgeon with extensive experience in drug development. Before joining Kyverna, he held leadership positions at Horizon Therapeutics, Genentech, Amgen, and Roche. Dr. Borie has an extensive publication history with over 50 publications in peerreviewed journals, 10 book chapters, and four issued patents. He received his Ph.D. in transplantation immunology from the University of Paris V Descartes and his M.D., Masters degree in Immunology, and Certificate of Immunology and Immunopathology from the University of Paris XII.
Session Abstract – PMWC 2024 Silicon Valley
Track 1 - January 24 9.00 A.M.-4.45 P.M.
Track Co-Chairs:
Yael Weiss, Mahzi Tx
Peter Marks, FDA
- PMWC 2024 Award Ceremony
Pioneer Honoree: Katherine A. High, AskBio
Pioneer Honoree: Timothy Yu, Boston Children's Hospital
- Piloting Interventional Genomics for Orphan Diseases
Keynote: Timothy Yu, Boston Children's Hospital
- Accelerated Approval for Small Populations: Biomarkers & Endpoints (PANEL)
Chair: Peter Marks, FDA
- Jennifer Puck, UCSF
- Katherine A. High, Rockefeller University
- Jennifer Panagoulias, FAST (Angelman Syndrome Foundation)
- Timothy Yu, Boston Children's Hospital - Novel Clinical Design Approaches in Rare Diseases (PANEL)
Chair: Adam Shaywitz, Bridge Bio
- Salvador Rico, Encoded Therapeutics
- Eric Crombez, Ultragenyx
- Elizabeth Berri Kravis, Rush University
- Empowering Patient Advocacy in Rare Disease Therapies (PANEL)
Chair: Yael Weiss, Mahzi Tx
- Charlene Son Rigby, STXBP1 Foundation
- Michael Graglia, Syngap Research Fund
- Wendy Erler, Alexion Pharmaceuticals - Advancing the Frontier: Gene Editing for Rare Diseases (PANEL)
Chair: Matthew Porteus, Stanford
- David Lebwohl, Intellia Therapeutics
- Pooja Agarwal, BioMarin Pharmaceutical
- James Chung, Kyverna Therapeutics
- Lucas Harrington, Mammoth Biosciences - Advancing the Frontier: Gene and Cell Therapies for Rare Diseases (PANEL)
Chair: Morten Sogaard, Astellas Gene Therapies
- Swati Tole, Capsida Biotherapeutics
- David Kirn, 4dmt
- Adrian Veres, Dyno Therapeutics
- Thomas Wechsler, J&J
- PMWC Showcase
- Dominic Borie, Kyverna Therapeutics
